TOTALTHERAPY A RETHINK SOLUTION
LIVE

Serial Number

97312413

Owner

Rethink Autism, Inc.

Attorney

Mark Stignani

First Use Date

May 22, 2022

Filing Date

Mar 15, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TOTALTHERAPY A RETHINK SOLUTION Trademark

Serial Number: 97312413 • Registration: 7836411

TOTALTHERAPY A RETHINK SOLUTION is a trademark filed by Rethink Autism, Inc. on March 15, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Rethink Autism, Inc. (9 trademarks)

49 West 27th Street
New York, NY 10001

Entity Type: 03

Trademark Details

Filing Date

March 15, 2022

Registration Date

June 17, 2025

First Use Anywhere

May 22, 2022

First Use in Commerce

May 22, 2022

Published for Opposition

January 9, 2024

Goods & Services

Downloadable computer software in the field of healthcare practice management that enables users to utilize electronic tools to support clinical practice, namely, software for scheduling, billing, accessing electronic health records, and collecting health, treatment, and outcome data; Downloadable computer software to optimize clinical workflow efficiency and generate recommendations for treatment, monitoring and management of patient behavior, treatment and education completion; Downloadable healthcare software to assist clinicians to electronically deliver bi-directional information to patients, guardians, and family members about treatments and other related topics

Online non-downloadable software for a clinician to manage a healthcare practice, namely, software that allows users to access management tools that enable the users to perform online scheduling, billing, electronic health records, and data collection services; Providing a website featuring technology that enables users to access a database and online non-downloadable tools for the optimization of clinical workflow by generating recommendations for treatment, monitoring and managing patient behavior, treatment, and education completion; providing a website featuring technology that enables clinicians to electronically deliver bidirectional information to patients, guardians, and family members about treatments and other related topics

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 17, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 25, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 25, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 25, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 25, 2025 AITU
USE AMENDMENT FILED
Mar 4, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 4, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 4, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 4, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 4, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 4, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 5, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2023 CRFA
ASSIGNED TO LIE
Dec 4, 2023 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 29, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 30, 2023 GNFN
FINAL REFUSAL E-MAILED
Mar 30, 2023 GNFR
FINAL REFUSAL WRITTEN
Mar 30, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 29, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 29, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 29, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2022 NWOS
NEW APPLICATION ENTERED
Mar 18, 2022 NWAP